The mission of Lohocla Research Corporation is to use genetic, genomic, and proteomic technology, in conjunction with rational, computational drug design, to develop diagnostic and therapeutic products for neurologic, mental illness and/or addictive disorders.
Lohocla is a proactive biotech company that is actively looking for new diagnostic and therapeutic products to better the lives of individuals around the world. We are always interested in joint-venture and partnerships opportunities that will help us to help them. Lohocla is different and wants to make a difference in people’s lives.
Making a difference in people’s lives by being at the forefront of neurogenetics and neuropharmacology.
The lifeline of the company is its ability to use genetics, genomics, proteomics, and novel drug design to make innovative discoveries. We use our expertise and rational design experience to develop new ideas to keep our innovation pipeline full.
We conduct our business with the utmost honesty and integrity. All employees and representatives of the corporation act according to the highest ethical standards.
We work towards one goal: developing products that improve people’s lives.
Our scientific team has vast experience in gentics, genomics, proteomics, and molecule design. We maintain our advantage through continuing education and the continuous development of our skills.